Hypofractionation in radiotherapy

Clinical and Translational Oncology

Volumn 9, Issue 1, 2007, Pages 21-27

  Pedraza Muriel, Vicente ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

Clinical radiotherapy; Fractiondose; Irradiationtime; Malignanttumours; Normaltissues; Radiationdose Biological effect

Indexed keywords

ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DOSIMETRY; HEAD AND NECK CARCINOMA; HUMAN; MALIGNANT NEOPLASTIC DISEASE; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIATION RESPONSE; RADIATION USE EFFICIENCY; TREATMENT DURATION; NEOPLASM; REVIEW;

DOSE FRACTIONATION; HUMANS; NEOPLASMS;

EID: 34547556527     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-007-0005-8     Document Type: Article

References (47)

1. Baclesse F (1958) Clinical experience with ultrafractionated radiotherapy. Progress in Radiation Therapy, Grune Stratton, New York, pp 128-148
2. Paterson R (1963) The treatment of malignant diseases by radiotherapy. Williams Wilkins, Baltimore
3. Fletcher GH. (1983) Keynote address: The scientific basis of the present and future practice of clinical radiotherapy. Int J Radiat Oncol Biol Phys 9:1073-1082
4. Withers HR (1985) Biological basis for altered fractionation schedules. Cancer 55:2086-2095
5. Fowler JF (1989) The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 62:679-684
6. Chadwick KH, Leenhouts HP (1973) A molecular theory of cell survival. Phys Med Biol 13:78-87
7. Kellerer AM, Rossi HH (1978) A generalized formulation of dual radiation action. Radiat Res 75:471-488
8. Alper T (1979) Cellular Radiobiology. London University Press, London
9. McBride WH, Withers HR (2004) Biologic Basis of Radiation Therapy. Principles and Practice of Radiation Oncology. Perez CA, Brady LH, Halperin EC, Schmidt- Ullrich RK, Eds. Lippincott Williams Wilkins, Philadelphia, pp 96-136
10. Dutreix J, Wambersie, A, Bounik C (1973) Cellular recovery in human skin reactions: Applications to dose, fraction number and overall time relationships in radiotherapy. Eur J Cancer 9:159-167
11. Pedraza V (2002) The biological basis of fractionation in radiotherapy. Rev Oncol 4:161-165
12. Withers HR, McBride WH (1999) Radiation effects on normal tissues. Front Radiat Ther Oncol 32:1-8
13. Withers HR. The Four R's of Radiotherapy. Advances in Radiation Biology. Lett JT, Adler H, eds. Academic Press, New York, pp 241-245
14. Withers HR, Taylor JMG, Maciejewski B (1988) The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 27:131-146
15. Pedraza V, Guerrero Tejada R, Luna del Castillo JD (2001) Time-dose response relationships relationships in postoperatively irradiated patients with head and neck squamous cell carcinomas. Radiother Oncol 60:137-145
16. Peters LJ, Withers HR (1997) Applying radiobiological principles to combining modality treatment for head and neck cancer. The time factor. Int J Radiat Oncol Biol Phys 59:831-836
17. MacKillop WJ, Bates JHT, O'Sullivan MB, Whiters HR (1996) The effect of delay in treatment on local control by radiotherapy. Int J Radiat Oncol Biol Phys 34:243-250
18. Al-Dweri FMO, Guirado D, Lallena AM, Pedraza V (2004) Effect on tumour control of time interval between surgery and postoperative radiotherapy: an empirical approach using Monte Carlo simulation. Phys Med Biol 49:2827-2839
19. Pedraza V (2003) Dose-time relationships in fractionated radiotherapy for cancer. Rev Oncol 5:49-54
20. Barendsen GW (1982) Dose fractionation, dose rate and isoeffect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys 8:1981-1997
21. Withers HR (1989) Failla Memorial Lecture: Contrarian Concepts in the Progress of Radiotherapy. Radiation Research 119: 395-412
22. Hall EJ (2000) Time, Dose and Fractionation in Radiotherapy. Radiobiology for the Radiologist, 5th Edn. Lippincott Williams Wilkins, Philadelphia, pp 397-418
23. Pedraza V (2006) The impact on oncology of the interaction of radiation therapy and radiobiology. Clin Transl Oncol 8:83-93
24. Dische S, Saunders MI, Barrett A et al (1997) A randomized multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 44:123-136
25. Bentzen S, Saunders MI, Dische S (1999) Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer. Radiother Oncol 52:219-226
26. Hall EJ (2006) Time, Dose and Fractionation in Radiotherapy. Radiobiology for the Radiology, 6th. Hall EJ, Giaccia AJ, Eds. Lippincott Williams Wilkins, Philadelphia, pp 378-397
27. Brenner DJ, Hall EJ (1999) Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 43:1095-1101
28. Duchesne GM, Peters LJ (1999) What is the α/β ratio for prostate cancer? Rationale for hypofractionated high-dose rate brachytherapy. Int J Radiat Oncol Biol Phys 44:747-748
29. Brenner DJ, Martínez A, Edmundson GK et al (2002) Direct evidence that prostate tumors show high sensitivity to fractionation (low a/β ratio), similar to late-responding normal tissue. In J Radiat Oncol Biol Phys 52:6-13
30. Fowler JF, Chappell RJ, Ritter MA (2001) Is a/β for prostate tumors really low? Int J Radiat Oncol Biol Phys 50:1021-1031
31. King CR, Fowler JF (2001) A simple analytic derivation suggest that prostate cancer a/β ratio is low. Intv J Radiat Oncol Bio Phys 51:213-214
32. Wang JZ, Guerrero M, Li XA (2003) How low is the a/β ratio for prostate cancer? Int J Radiat Oncol Biol Phys 55:194-203
33. Wang CJ, Leung SW, Chen HC et al (1998) The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: Evidence suggestive of consequential late effect (CQLE). Int J Radiat Oncol Biol Phys 40:85-91
34. Dorr W, Hendry JH (2001) Consequential late effects in normal tissues. Radiother Oncol 61:223-231
35. van der Kogel AJ, Jarrett KA, Paciotti MA et al (1988) Radiation tolerance of the rat rectum to fractionated X-rays and pimesons. Radiother Oncol 12:225-232
36. Dewit L, Oussoren Y, Bartelink H et al (1989) The effect of cisdiamminechloroplatinum (II) on radiation damage in mouse rectum after fractionated irradiation. Radiother Oncol 16:121-128
37. Collins CD, Lloyd-Davies RW Swan AV (1991) Radical external beam radiotherapy for localised carcinoma of the prostate using a hypofractionated technique. Clin Oncol 3:127-132
38. Logue JP, Cowan RA, Hendry JH (2001) Hypofractionation for prostate cancer. Int J Radiat Oncol Biol Phys 49:1522-1523
39. Livsey JE, Cowan RA, Wylie JP et al (2003) Hypofractionated conformal radiotherapy in carcinoma of the prostate: Five-year outcome analysis. Int J Radiat Oncol Biol Phys 57:1254-1259
40. Brenner DJ (2003) Hypofractionation for prostate cancer radiotherapy. What are the issues? Int J Radiat Oncol Biol Phys 57:912-914
41. Fowler JF, Ritter MA, Chappell RJ, Brenner DJ (2003) What hypofractionated protocols should be tested for prostate cancer? Int J Radiat Oncol Biol Phys 56: 1093-1104
42. Kupelian PA, Reddy CA, Carlson TP et al (2002) Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer. Int J Radiat Oncol Biol Phys 53:904-912
43. Galalae RM, Martínez A, Mate T et al (2004) Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer. Int J Radiat Oncol Biol Phys 58:1048-1055
44. Fowler JF (2005) The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncol 44:265-276
45. Strandqvist M (1944) Studien uber die kumulative wirkung der roentgenstrahlen bei fractionierung. Acta Radiol (Stockholm) 55[Suppl 1]:S1-S300
46. Fletcher GH, Shukovsky LJ (1976) Isoeffects exponents for the production of dose-response curves in squamous cell carcinomas treated between 4 to 8 weeks. J Radiol Electrol 57:825-827
47. Fowler JF, Lindstrom M (1992) Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 23:457-467